High-concentration Ropivacaine

PreclinicalSmall molecule

CChengdu Jinjiang Maternity and Child Health Hospital

High-concentration Ropivacaine is one of 4 small molecule programs targeting Labor Analgesia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Labor AnalgesiaNot yet recruiting

Labor AnalgesiaPreclinical

Not yet recruiting

Competition

Competitive Landscape

4 competitors in Labor Analgesia

#DrugCompanyPhaseTrials

Iheezo

BB. Braun Medical Inc.

Approved

1 2

Chirocaine

PPurdue Pharma LP

Preclinical

4 3

Hyperbaric Bupivacaine

TTanta University

Preclinical

1 4

High-concentration Ropivacaine

CChengdu Jinjiang Maternity and Child Health Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Labor Analgesia1 trial

Effects of Ropivacaine Concentrations on Prolonged Labor Analgesia

Not yet recruiting·—·N/A·NCT07007650·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for High-concentration Ropivacaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — High-concentration Ropivacaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for High-concentration Ropivacaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Chengdu Jinjiang Maternity and Child Health Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CChengdu Jinjiang Maternity and Child Health Hospital

High-concentration Ropivacaine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Labor Analgesia1 trial

References

Drug Info

Quick Facts

Related News